BNKL — Bionik Laboratories Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $1.73m
- $1.81m
Brief: Bionik Laboratories Enters Into Distribution Agreement With Pro-Med Technology For The Sale Of Inmotion® Robotic Devices In Hong Kong
Brief: Bionik Laboratories acquires Florida Rehabilitation Center first in strategic national rollout
Brief: Bionik Laboratories Reports Q1 Revenue Of $200,000
Brief: Bionik Laboratories Says Chief Commercial Officer, Terminated Other Than For Cause From Employment, Officer Positions With Co, Units
Brief: BIONIK Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results
Brief: Bionik Laboratories Reports Q3 2021 Financial Results
Brief: Bionik Labs Announces Regulatory Approval And First Sale Of Its Inmotion Arm Robotic Technology
Brief: Bionik Laboratories Reports Q3 Loss Per Share $0.03
Brief: Bionik Laboratories reports second quarter fiscal year 2018 financial results
Brief: Bionik Laboratories Corp announces capital raise through issuance of convertible notes